Microbial Biotech 2012,

5:106–115 CrossRef 22 Nollevaux

Microbial Biotech 2012,

5:106–115.CrossRef 22. Nollevaux G, Devillé C, GDC941 el Moualij B, Zorzi W, Deloyer P, Schneider YJ, Peulen O, Dandrifosse G: Development of a serumfree co-culture of human intestinal epithelium cell-lines (Caco-2/HT29–5 M21). BMC Cell Biol 2006, 7:20.PubMedCentralPubMedCrossRef 23. Parlesak A, Haller D, Brinz S, Baeuerlein A, Bode C: Modulation of cytokine release by differentiated CACO-2 cells in a compartmentalized coculture model with mononuclear leucocytes and nonpathogenic bacteria. Scand J Immunol 2004, 60:477–485.PubMedCrossRef 24. Höner zu Bentrup K, Ramamurthy R, Ott CM, Emami K, Nelman-Gonzalez K, Wilson JV, LY3023414 price Richter EG, Goodwin TJ, Alexander JS, Pierson DL, Pellis N, Buchanan KL, Nickerson CA: Three-dimensional organotypic models of human colonic epithelium to study the early stages of enteric salmonellosis. Microbes Infect 2006, 8:1813–1825.PubMedCrossRef 25. Kim HJ, Huh D, Hamilton G, Ingber DE: Human gut-on-a-chip inhabited by microbial flora that experiences intestinal peristalsis-like motions and flow. Lab Chip 2012, 12:2165–2174.PubMedCrossRef 26. Jensen GS, Redman

KA, Benson KF, Carter SG, Mitzner MA, Reeves S, Robinson L: Antioxidant bioavailability and rapid immune-modulating effects after consumption of a single acute MG-132 mouse dose of a high-metabolite yeast immunogen: results of a placebo-controlled double-blinded crossover pilot study. J Med Food 2011, 14:1002–1010.PubMedCentralPubMedCrossRef 27. Moyad

MA, Robinson LE, Kittelsrud JM, Reeves SG, Weaver SE, Guzman AI, Bubak ME: Immunogenic yeast-based fermentation product reduces allergic OSI-027 in vivo rhinitis-induced nasal congestion: a randomized, double-blind, placebo-controlled trial. Adv Ther 2009, 26:795–804.PubMedCrossRef 28. Moyad MA, Robinson LE, Zawada ET, Kittelsrud J, Chen DG, Reeves SG, Weaver S: Immunogenic yeast-based fermentate for cold/Flu-like symptoms in nonvaccinated individuals. J Altern Complement Med 2010, 16:213–218.PubMedCrossRef 29. Possemiers S, Verhelst A, Maignien L, van den Abbeele P, Reeves SG, Robinson LE, Raas T, Pluvinage P, Schneider Y, van de Wiele T, Marzorati M: A dried yeast fermentate selectively modulates both the luminal and mucosal gut microbiota, enhances butyrate production and protects against inflammation, as studied in an intergrated in vitro approach. 2013, Agric. Food Chem 2013, 61:9380–9392.CrossRef 30. Nickerson CA, Ott CM, Wilson JW, Ramamurthy R, LeBlanc CL, Höner zu Bentrup K, Hammond T, Pierson DL: Low-shear modeled microgravity: a global environmental regulatory signal affecting bacterial gene expression, physiology, and pathogenesis. J Microbiol Methods 2003, 54:1–11.PubMedCrossRef 31.

Comments are closed.